PFE logo

PFE
Pfizer Inc

105,443
Mkt Cap
$140.21B
Volume
163.6M
52W High
$28.00
52W Low
$20.92
PE Ratio
13.12
PFE Fundamentals
Price
$24.27
Prev Close
$24.66
Open
$24.39
50D MA
$24.77
Beta
0.41
Avg. Volume
61.31M
EPS (Annual)
$1.41
P/B
1.58
Rev/Employee
$785,518.52
Loading...
Loading...
News
all
press releases
Stock Bulls Get a Wake-Up Call from Wall Street CEOs Open Interest 11/04/2025
Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Warning signs. Wall Street CEOs say investors should brace for a 10% correction in the next 12 to...
Bloomberg Markets and Finance-YouTube·3h ago
News Placeholder
More News
News Placeholder
Pfizer and Novo Nordisk both raise bids for Metsera
CNBC's David Faber breaks down the latest details about a bidding war between Pfizer and Novo Nordisk for Metsera...
CNBC Television-YouTube·4h ago
News Placeholder
Earnings Data Deluge
Earnings Data Deluge
Zacks·6h ago
News Placeholder
Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools
Pfizer posts Q3 earnings beat and raises EPS guidance, but weaker COVID product sales weigh on overall revenue momentum.
Zacks·6h ago
News Placeholder
Pre-markets Sell Off on No New Economic News
This morning was to bring us new U.S. Trade Deficit figures, Factory Orders and JOLTS, but due to the government shutdown are not out.
Zacks·6h ago
News Placeholder
Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·7h ago
News Placeholder
Metsera says Novo Nordisk's new bid for obesity drugmaker is 'superior' to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in...
CNBC: Top News·7h ago
News Placeholder
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters
Metsera said that it would be entitled to terminate its merger agreement with Pfizer if Novo’s proposal continues to be superior.
Stocktwits·7h ago
News Placeholder
Should You Buy Moderna Stock Ahead of Q3 Earnings Report?
MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.
Zacks·8h ago
News Placeholder
Stock Market Today: U.S. Stock Futures Sag As Gov't Shutdown Ties for Record
This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Tuesday. This is TheStreet's Stock...
TheStreet.com·9h ago

Latest PFE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.